Inspiration
The difficulty in diagnosing rare diseases, often due to limited reference data and the complexity of genome sequencing, inspired us. Many patients suffer from delayed diagnoses or misdiagnoses, leading to improper treatment. We wanted to leverage AI to make a real impact in the medical field, improving the accuracy and speed of detecting rare genetic conditions. AI's ability to analyze vast genomic data quickly and identify hard-to-find mutations presents a groundbreaking opportunity to transform rare disease detection and personalize treatment.
What it does
Our platform uses AI to analyze genome sequencing (GS) data, detecting rare genetic mutations that traditional methods often miss. It employs deep learning algorithms to identify known mutations and novel anomalies, which may indicate a rare disease. The platform provides a comprehensive analysis by integrating multi-omics data, enhancing detection accuracy. It also offers clinical decision support by visualizing the results and providing risk assessments for healthcare professionals, aiding in faster and more accurate diagnosis and treatment planning.
How we built it
We used deep learning frameworks like TensorFlow and PyTorch to develop the core model, training it on publicly available genomic datasets such as GnomAD and 1000 Genomes Project. The model was fine-tuned to detect both common and rare genetic mutations. We integrated various types of omics data, including transcriptomics and proteomics, to create a more robust analysis. The platform also features a user-friendly interface that allows clinicians to input sequencing data and receive actionable insights, backed by AI-driven predictions and visualizations.
Challenges we ran into
We faced several challenges, including:
Data scarcity: Rare disease datasets are inherently limited, making it difficult to train models. To address this, we employed transfer learning techniques. Model complexity: Integrating multiple data types (genomics, proteomics, etc.) into a single framework was technically challenging. Interpretability: Ensuring the AI model’s outputs were interpretable and actionable for clinicians required building sophisticated visualization and decision-support tools.
Accomplishments that we're proud of
We’re proud of successfully building a platform that can accurately detect rare genetic mutations and integrate multi-omics data for enhanced diagnostic capabilities. Our AI model has shown significant promise in identifying novel genetic patterns that could indicate rare diseases. Additionally, creating a user-friendly interface for clinicians to interpret and use AI-generated insights is a major step towards making cutting-edge technology accessible in the healthcare sector.
What we learned
Throughout the development process, we learned the importance of data diversity and quality when dealing with complex genetic information. We also gained insights into the challenges of combining AI with medical applications, particularly in making AI models interpretable and useful in a clinical setting. Understanding the nuances of rare diseases and how AI can improve patient outcomes deepened our appreciation for the potential of AI in healthcare.
What's next for AI-Driven Genome Analysis for Rare Disease Detection
In the future, we aim to:
Expand the dataset: Partner with medical institutions to acquire more genomic data for improved model accuracy and reliability. Enhance interpretability: Continue refining our clinical interface to offer more detailed and understandable insights. Real-world testing: Collaborate with hospitals and research institutions to test the platform in real-world diagnostic settings. Integration with electronic health records (EHR): Incorporate patient health data from EHR systems to provide even more personalized insights. Support for novel disease research: Use AI-driven insights to contribute to the discovery of new genetic links to rare diseases.
Log in or sign up for Devpost to join the conversation.